The HIV drug Pre Exposure Prophylaxis (PrEP) is meant for high risk groups like sex workers, teenagers and gay communities whose vulnerability to the virus is high. Kioko said Kenya’s regulatory authorities have approved the pill. “The PrEP is a critical intervention in HIV prevention. It is only meant for HIV negative people and has over 96 per cent efficacy,” said Kioko.

He revealed the HIV pill is already being sold at selected private health facilities for 0.20 U.S. dollars but will soon be available for free in government-run health facilities. Likewise, the HIV self-testing kit will be available at pharmacies and private clinics at a cost of 8 dollars and will help reduce the number of Kenyans who are not aware of their status.

Kioko said the ministry of health intends to avail self-testing kits to an estimated 400,000 HIV-positive individuals unaware of their status. “The self-testing will be accompanied by a confirmatory test in government laboratories." “It is integrated in Kenya’s AIDS Strategic Framework that aims to reduce new infections by 75 per cent,” said Kioko. Kenya has an estimated 1.5 million people living with AIDS and two thirds of them are already enlisted in a treatment program subsided by the state.

The Head of National Aids and STI Control Program Martin Sirengo said unveiling of an efficacious and cheaper drug to prevent HIV transmission alongside self-testing kit will hasten progress towards making Kenya an AIDS-free nation.

Source:Pulse Nigeria